Article title: Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial
Authors: Mora, J. S., Genge, A., Chio, A., Estol, C. J., Chaverri, D., Hernández, M., Marín, S., Mascias, J., Rodriguez, G. E., Povedano, M., Paipa, A., Dominguez, R., Gamez, J., Salvado, M., Lunetta, C., Ballario, C., Riva, N., Mandrioli, J., Moussy, A., Kinet, J. -P., Auclair, C., Dubreuil, P., Arnold, V., Mansfield, C. D., Hermine, O., & on behalf of the AB10015 STUDY GROUP
Journal: Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Bibliometrics: Volume 21, Number 1–2, pages 5–14
DOI: https://doi.org/10.1080/21678421.2019.1632346
The following sentence “OH is the President of the Scientific Committee of AB Science.” under the “Declaration of interest” section was incorrect when the article was first published online.
This sentence has now been updated as follows “OH is a co-founder, shareholder, and the President of the Scientific Committee of AB Science.” and the article has been republished online.